Citation Impact
Citing Papers
Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq
2015 StandoutScience
The Serine Protease TMPRSS6 Is Required to Sense Iron Deficiency
2008 StandoutScienceNobel
Iron overload in the organism as a health problem
1999
RESEARCH ON HEAVY METALS IN POLAND
2009 Standout
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Emerging therapies for the treatment of hepatitis C
2013 StandoutNobel
Retinal Vascular Caliber in Persons with Type 2 DiabetesThe Wisconsin Epidemiological Study of Diabetic Retinopathy: XX
2006
HFE mutations, hepatic iron, and fibrosis: Ethnic-specific association of NASH with C282Y but not with fibrotic severity
2002
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
2006 Standout
Diabetic retinopathy
2010 Standout
Liver fibrosis
2005 Standout
Iron Toxicity and Chelation Therapy
2002
The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease
2008
Mechanisms of liver fibrosis
2005
From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation
2014 Standout
Liver fibrosis – from bench to bedside
2003 Standout
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
2004 Standout
Major Mango Polyphenols and Their Potential Significance to Human Health
2008 Standout
Decreased Liver Hepcidin Expression in the Hfe Knockout Mouse
2002
Hemochromatosis and Iron-Overload Screening in a Racially Diverse Population
2005
Balancing Acts
2004 Standout
The causes of porotic hyperostosis and cribra orbitalia: A reappraisal of the iron‐deficiency‐anemia hypothesis
2009 Standout
Tissue-resident macrophages
2013 Standout
Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis
2008 Nature
Analysis of boceprevir resistance associated amino acid variants (RAVs) in two phase 3 boceprevir clinical studies
2013
New and experimental therapies for HCV
2009
Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1
2012
Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy
2010 Standout
Interferon-based therapy for chronic hepatitis C: current and future perspectives
2008
A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
Enhanced γ-Glutamyl Transpeptidase Expression and Selective Loss of CuZn Superoxide Dismutase in Hepatic Iron Overload
1998
Mechanisms of Hepatic Fibrogenesis
2008 Standout
A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload
2001 Standout
Recent advances in hemochromatosis: a 2015 update
2015
Resistance to Direct Antiviral Agents in Patients With Hepatitis C Virus Infection
2009
Treatment of Chronic HCV Infection in Special Populations
2006
The role of iron in brain ageing and neurodegenerative disorders
2014 Standout
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Nonalcoholic fatty liver disease
2005 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Non-invasive assessment of liver fibrosis progression in hepatitis C patients retreated for 96 weeks with antiviral therapy: a randomized study
2010
Translating an Understanding of the Pathogenesis of Hepatic Fibrosis to Novel Therapies
2013
Disorders of Iron Metabolism
1999 Standout
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
2010
Co-trafficking of HFE, a Nonclassical Major Histocompatibility Complex Class I Protein, with the Transferrin Receptor Implies a Role in Intracellular Iron Regulation
1998
Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment
2014 Standout
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
2011 Standout
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Diagnosis and management of hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases
2011
Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages
2012 Standout
Review article: specifically targeted anti‐viral therapy for hepatitis C – a new era in therapy
2010
Treatment of HCV Infection by Targeting MicroRNA
2013 Standout
Brain iron metabolism: Neurobiology and neurochemistry
2007
Cancer of the Ovary
2004 Standout
HEPATIC FIBROSIS
2001
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation
2011
Hepcidin: A putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease
2001
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Magnetic targeting for site-specific drug delivery: applications and clinical potential
2009
Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells
2012 StandoutNobel
Printed educational materials: effects on professional practice and healthcare outcomes
2012 Standout
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
2004 Standout
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
2003 Standout
Tissue-Specific Regulation of Iron Metabolism and Heme Synthesis: Distinct Control Mechanisms in Erythroid Cells
1997
CSF-1–Dependent Red Pulp Macrophages Regulate CD4 T Cell Responses
2011 StandoutNobel
Progress towards a hepatitis C virus vaccine
2013 StandoutNobel
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Impact of the introduction of a guideline on the targeted detection of hereditary haemochromatosis.
2005
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Advances in Supramolecular Chemistry
1997
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents
2014 StandoutNobel
The Hereditary Nonpolyposis Colorectal Cancer Syndrome: Genetics and Clinical Implications
2003
Absolute asymmetrische Synthese: Ursprung, Beeinflussung und Verstärkung von Chiralität
1999 StandoutNobel
Hepatitis C Virus Genotype 5a Subgenomic Replicons for Evaluation of Direct-Acting Antiviral Agents
2014 StandoutNobel
Guidelines for the management of hemophilia
2012 Standout
Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants
2009 StandoutNobel
Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
2003 Standout
HFE Genotype in Patients with Hemochromatosis and Other Liver Diseases
1999
Works of B.R. Bacon being referenced
An Update on Iron Metabolism: Summary of the Fifth International Conference on Disorders of Iron Metabolism
1996
Hemochromatosis: Diagnosis and management
2001
Knockout of the mouse HFE gene produces hemochromatosis
1998
104 BOCEPREVIR (B) COMBINATION THERAPY IN NULL RESPONDERS (NR): RESPONSE DEPENDENT ON INTERFERON RESPONSIVENESS
2008
Hereditary hemochromatosis: presentation and diagnosis in the 1990s.
1997
1049 PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED STUDY OF NITAZOXANIDE PLUS PEGINTERFERON AND RIBAVIRIN IN HCV GENOTYPE 1 PATIENTS: INTERIM ANALYSIS SHOWS INCREASE IN EVR
2009
Effect of vitamin E supplementation on hepatic fibrogenesis in chronic dietary iron overload
1997
Retinal Abnormalities Associated With Anemia
1983
977 The presence of severe steatosis or steatohepatitis impairs response to antiviral therapy in patients with chronic hepatitis C
2003